Purpose: The outcome of infrainguinal bypass surgery for limb salvage has traditionally been assessed by graft patency rates, limb salvage rates, and patient sur vival rates. Recently, functional outcome of limb salvage surgery has been assessed by patient ambulatory status and independent living status. These assessments fail to consider the adverse long-term patient effects of delayed wound healing, episodes of recurrent ischemia, and need for repeat operations. An ideal result of infrainguinal bypass surgery for limb salvage includes an uncomplicated operation, elimination of ischemia, prompt wound healing, and rapid return to premorbid functional status without recurrence or repeat surgery. The present study was performed to determine how often this ideal result is actually achieved. Methods: The records of 112 consecutive patients who underwent initial infrainguinal bypass surgery for limb salvage 5 to 7 years before the study were reviewed for operative complications, graft patency, limb salvage, survival, patient functional status, time to achieve wound healing, need for repeat operations, and recurrence of ischemia. Results: The mean patient age was 66 years. The mean postoperative follow-up was 42 months (range, 0 to 100.1 months). After operation 99 patients (88%) lived independently at home and 103 (92%) were ambulatory. There were seven perioperative deaths (6.3%), and wound complications occurred in 27 patients (24%). By life table, the assisted primary graft patency and limb salvage rates of the index extremity 5 years after operation were 77% and 87%, respectively, and the patient survival rate was 49%. At last follow-up or death, 73% of the patients (72 of 99) who lived independently at home before the operation were still living independently at home, and 70% (72 of 103) of those who were ambulatory before the operation remained ambulatory. Wound (operative and ischemic) healing required a mean of 4.2 months (range, 0.4 to 48 months), and 25 patients (22%) had not achieved complete wound healing at the time of last follow-up or death. Repeat operations to maintain graft patency, treat wound complications, or treat recurrent or contralateral ischemia were required in 61 patients (54%; mean, 1.6 reoperations/patient), and 26 patients (23.2%) ultimately required major limb amputation of the index or contralateral extremity. Only 16 of 112 patients (14.3%) achieved the ideal surgical result of an uncomplicated operation with long-term symptom relief, maintenance of functional status, and no recurrence or repeat operations. Conclusions: Most patients who undergo infrainguinal bypass surgery for limb salvage require ongoing treatment and have persistent or recurrent symptoms until their death. A significant minority have major tissue loss despite successful initial surgery. Clinically important palliation is frequently achieved by bypass surgery, but ideal results are distinctly infrequent. (J Vasc Surg 1998;27:256-66.)
accurate assessment of wound healing, recurrence of ischemia, and return to functional status, patients were excluded from the study if they remained alive but were lost to follow-up before 2 years.
Data were obtained from retrospective review of patient records. Additional data were obtained regarding deceased patients and patients whose records did not contain adequate information by interview of patients, surviving family members, and referring physicians. The Oregon Bureau of Vital Statistics provided information regarding the date and cause of death for patients whose terminal care was not provided at OHSU. Patients underwent IB according to the principals previously described in detail by our division. [7] [8] [9] The important points include preoperative and postoperative noninvasive vascular laboratory testing, detailed preoperative arteriography, use of autologous vein for infrainguinal grafts, and multiteam surgery.
After operation patients were seen as often as necessary until wound healing was complete. Routine postoperative vascular laboratory surveillance of vein grafts using duplex scanning was performed every 3 months for the first postoperative year and every 6 months thereafter. Graft stenoses discovered by duplex scanning were confirmed by arteriography and were electively repaired if they exceeded 50% diameter reduction determined by arteriography, as previously reported. 10 Postoperative outpatient wound management was supervised by the authors and performed by visiting nurses. Risk factor reduction was supervised by patients' referring physicians. All patients received daily aspirin therapy. Routine screening for hypercoagulable states was performed at the time of surgery. Patients who had positive test results were treated with long-term warfarin anticoagulation therapy unless there were contraindications.
For the purposes of this study, perioperative risk factors, indication for surgery, type of operation performed, and conduit used were recorded from the patient records. Operative results, including mortality and morbidity data, were also recorded from patient records. Life table determination of assisted primary graft patency rate, limb salvage rate, and patient survival rate was performed according to the suggested reporting standards of the Joint Vascular Societies. 2 Patient functional status was assessed by living situation and ambulatory status before the indication for IB arose, in the subsequent postoperative period, and at the time of last follow-up or death.
Results of lower extremity bypass surgery have traditionally been assessed by graft patency rate, limb salvage rate, and patient survival rate. Reporting standards for these outcome variables have been described and are widely used. 1, 2 Recently, increasing emphasis has been placed on the importance of integrating functional outcome measures with traditional assessments of patients who undergo lower extremity revascularization for peripheral vascular occlusive disease. Patient global health status, including function and well-being, has been evaluated by questionnaires such as the one described by the Medical Outcomes Study. 3 Specific questionnaires pertaining to patients with peripheral vascular occlusive disease have focused on non-limb-threatening manifestations of the disease, particularly intermittent claudication. 4 The few studies that have assessed functional outcomes in populations with limb-threatening ischemia have been limited to short-term follow-up. 5, 6 Previous functional outcome assessments have not directly considered the adverse long-term patient effects of delayed wound healing, episodes of recurrent ischemia, and the need for repeat operations. Most surgeons would agree that an ideal result after infrainguinal bypass (IB) for limb salvage includes elimination of ischemia, uncomplicated wound healing, and rapid return to premorbid functional status without the need for repeat leg operations. Certainly, this is what is logically expected by patients and frequently by referring physicians. The present study was performed to determine how often this ideal result is actually achieved.
METHODS
Patients included in the study underwent IB for limb salvage at the Oregon Health Sciences University Hospital (OHSU) from December 1988 to January 1991. This interval was chosen to include only patients whose procedure was performed sufficiently long ago to permit adequate assessment of long-term outcome. Limb salvage indications for surgery were defined as ischemic rest pain, ischemic ulcers or gangrene, acute ischemia, and an anklebrachial pressure index less than 0.4. Patients who met these criteria were included whether the operations were performed electively to treat chronic ischemia or were performed urgently or emergently to treat acute worsening of ischemia. To eliminate statistical errors from multiple observations, only patients who underwent their first IB for limb salvage at OHSU were included in the study. To allow an adequate postoperative time period for an February 1998 Living situation was classified as "home and independent" if patients were living alone, with a spouse, or with other family members; "home with assistance" if patients required home health nursing; and "dependent" if patients were living in a care facility (such as a nursing home or foster home). Ambulatory status was classified as "ambulatory" if patients walked independently or used a cane or walker, or "nonambulatory" (wheelchair-bound or bedbound).
Wound healing was assessed by the occurrence of wound-related complications and by the time required for healing. Wounds were regarded as healed when there was no epithelial defect and when wound care, including dressings and ointments, was no longer required. Wound-related complications included need for repeat hospitalization or surgery or need for additional wound-related treatment (such as antibiotics or a visiting nurse) The time required for healing of all wounds related to the procedure was recorded. The time required for healing of operative incisions was recorded separately from the time required for healing of ischemic wounds for which the surgery was performed. The total time recorded for healing of ischemic wounds included the time required for healing of secondary operations performed to treat areas of ischemic ulceration or gangrene (such as toe amputation or debridement). Wound healing time for repeat ipsilateral operations (such as graft revision or repeat grafting) or subsequent contralateral operations was not included in the total wound healing time, to permit assessment of the results of the original operation only and to eliminate the statistical problems of repeat observations. Secondary operations to treat the ischemic lesions responsible for the original surgery were recorded. Minor toe and foot amputations and foot debridement performed after IB to complete treatment of the original ischemic lesion were regarded as part of the original operation rather than as repeat surgery even if performed on a subsequent date. Wound care required to complete this portion of the treatment was not regarded as a wound complication. If more than one operation was required to treat ischemic lesions (such as amputation after debridement failed to heal or repeat debridement, or skin grafting), the second and all subsequent procedures were regarded as repeat operations. Repeat operations to treat graft complications or recurrent or contralateral disease were also recorded.
Patients were designated as having had an ideal result if there were no operative complications, if operative wounds and ischemic wounds healed without complication, if repeat surgery was not necessary, and if functional status returned to the level that existed before the onset of the indication for IB.
RESULTS
During the 3-year study period, 133 patients underwent IB for limb salvage for the first time at OHSU. Twenty-one patients (16%) were lost to follow-up less than 2 years from their initial operation without record of death and were excluded from the study, leaving 112 patients (84%) who constituted the study group.
Demographic factors, risk factors, operative indications, procedures performed, and conduits used for the 112 study patients are compared with those for the 21 excluded patients in Table I . Operative complications and deaths that occurred in the 112 study patients are compared with those that occurred in the 21 excluded patients in Table II . Except for a significant difference in the number of previous strokes that had occurred in the excluded patient group (28% vs 8%; p = 0.009), there were no significant differences between the two groups. The study population is therefore an appropriately representative majority of the entire population of patients who underwent IB for limb salvage during the study period. The mean duration of follow-up for study patients was 42 months (range, 0 to 100.1 months). Sixty-one patients died during follow-up at a mean interval of 25 months after surgery (range, 0 to 95.6 months). The mean follow-up for the 51 surviving patients was 62 months (range, 24.1 to 100.1 months).
Conventional analysis
The 6-month, 3-year, and 5-year assisted primary patency, limb salvage, and patient survival rates calculated by life table methods are shown in Table  III .
Functional outcome
Ambulatory status. Before the onset of the symptoms that caused the need for IB, 103 of the 112 study patients (92%) were ambulatory and nine (8%) were nonambulatory. After operation, of the 103 patients who were ambulatory before surgery, five (5%) died in the perioperative period, 87 (84%) were ambulatory, and 11 (11%) were nonambulatory. At last follow-up or death, 72 of the 103 patients (70%) who were ambulatory before operation remained ambulatory, and 26 (25%) were nonambulatory (Table IVA) . Three of the nine patients (33%) who were nonambulatory before operation regained ambulation after operation and remained ambulatory at last follow-up or death (Table IVA) .
Living status. Living status before operation was home and independent for 99 of 112 patients (88%), home with assistance for 10 patients (9%), and dependent for three patients (3%). After operation, of the 99 patients who were home and independent before the operation, seven (7%) died in the perioperative period, 65 (66%) were discharged home and independent, 17 (17%) were discharged home with assistance, and 10 (10%) were dependent. Six of the 10 patients (60%) who lived at home with assistance before operation resumed this status at hospital discharge, and the other four (40%) were dependent. All three patients who were dependent before operation remained dependent. Overall, at the time of last follow-up or death, 81 of 112 patients (72%) had maintained their preoperative living status, 28 (25%; including seven patients who died in the perioperative period) had declined in living status, and no patients had an improvement in living status. Information on living status at last follow-up or death was not available regarding the remaining three patients (3%). At the time of last follow-up or death 72 of the 99 patients (73%) who were home and independent before operation were still home and independent, four (4%) were home with assistance, and 14 (14%) were dependent; seven (7%) died in the perioperative period, and no information was available for the remaining two patients (2% ; Table IVB) .
Living and ambulatory status. Before surgery, 96 of 112 patients (86%) were ambulatory and home and independent. Of these 96 patients, 65 (68%) remained ambulatory and home and independent at the time of last follow-up or death (Table  IVB) .
Wound healing
Wound complications developed in 27 patients (24%) after operation, requiring treatment with antibiotics or nursing care or surgical debridement and drainage. The mean time to complete healing of all wounds, operative and ischemic, was 4.2 months (range, 0.4 to 48 months). Table V shows the time to wound healing for operative and ischemic 
Repeat operations
Repeat operations to maintain graft patency, to treat ongoing, recurrent, or contralateral ischemia, or to treat wound complications were required in 61 patients (54%). The mean number of repeat operations per patient during the study period was 1.6 (range, 0 to 10). These figures do not include 40 subsequent operations performed to treat the original ischemic lesions, which for purposes of this study were regarded as part of the original surgery even if performed on a subsequent date, as described in Methods. In all, 176 repeat operations were required. Eighty-nine (51%) of the repeat operations were vascular reconstructions (42 new grafts, 32 graft revisions, and 15 inflow procedures). Fifty-two of the repeat operations (29%) were amputations (26 major and 26 minor). The remaining 35 repeat operations (20%) consisted of wound debridement and drainage or skin grafting (Table VI) . Twentyseven patients (24%) required IB of their contralateral extremity subsequent to undergoing IB of the index extremity, and 63 of the total repeat operations (35%) were performed on the contralateral extremity, for a mean of 0.5 contralateral extremity operations per patient. By last follow-up or death, 15 patients (13%) required a subsequent major amputation of the ipsilateral leg and 11 patients (10%) required a subsequent major amputation of the contralateral leg.
Ideal results
Sixteen of 112 patients (14%) had ideal surgical results, which consisted of an uncomplicated operation with long-term symptom relief, maintenance of functional status, uncomplicated wound healing, and no recurrence or repeat operations regardless of postoperative survival time. Failure to achieve an ideal result was caused by operative death in seven patients (7%), by perioperative complications in 25 patients (26%), by failure to regain or maintain preoperative functional status in 28 patients (29%), by wound complications in 27 patients (28%), and by the need for repeat surgery in 61 patients (64%; Fig.  1 ).
DISCUSSION
Early reports of IB for limb-threatening ischemia cautioned against an overly aggressive surgical approach because of poor graft patency, limb salvage, and patient survival rates. [11] [12] [13] As experience with these operations increased and surgical technology, including lighting, instruments, and sutures improved, surgeons' technical skills also improved, resulting in marked improvement in the patency and limb salvage results reported for IB performed for limb-threatening ischemia. 7, [14] [15] [16] [17] [18] [19] [20] [21] The well documented poor outcomes after primary amputation appeared to support an aggressive approach to limb salvage. [22] [23] [24] [25] [26] Marked improvement in patency and limb salvage results characterized our own experience with IB for limb salvage, as was true for multiple other groups. 7, [14] [15] [16] [17] [18] [19] [20] [21] The present study was undertaken because of the anecdotal observation that despite excellent patency and limb salvage rates as judged by standard reporting practices, patients who underwent IB for limb salvage in our clinic appeared to follow a clinical course characterized by a frequent and ongoing need for care, including repeat hospitalizations for wound care and repeat surgery. An attempt to characterize and quantitate this clinical observation, familiar to many surgeons, constituted the basis for this study. It is not the purpose of this paper to suggest that the rapidly declining functional status and poor long-term survival rate documented in the limb salvage patient group are entirely or even primarily caused by either lower extremity ischemia or by the surgery performed for its treatment. Clearly, this is not the case. Rather, it is abundantly clear that limbthreatening ischemia is a manifestation of atherosclerosis that occurs in patients who are approaching the end of life, at a time when functional status is frequently declining rapidly and interval survival is short. The data available for this retrospective study did not permit determination of the specific causes of decline in functional status or need for nursing home placement. What is clear from this study is that surgical treatment of the ischemic limb(s) by IB appears to do little to change this state.
For several reasons, patency and limb salvage data are less than ideal parameters for assessment of results of limb salvage surgery. Most reports contain the results of institutions' entire experience with IB, which means that many patients are included who have short-term follow-up. The effect of "frontloading" data evaluated by life table is to favorably bias the results when long-term outcome is censored by death of many patients, as described by Myers et al. 27 Patency assesses the results of an individual operation. Limb salvage assesses the results of an operation on a single limb. Neither parameter permits assessment of the total effect of an operation on the patient. After all, from the patient's point of view, it matters little whether a repeat operation required after initially successful IB for limb salvage is performed on the contralateral limb for new symptoms, on the ipsilateral limb for a wound problem, on the ipsilateral limb for revision of a graft stenosis, or on the ipsilateral limb for recurrent ischemia caused by development of a stenosis in the inflow vessel, although each of these events has a very different implication with respect to parameters that assess the results of the original operation. From the patient's perspective, repeat hospitalization and surgery, postoperative wound healing, and the necessary clinic visits are indistinguishable from the original episode. The current study documents that wound complications and recurrent or persistent ischemia of the ipsilateral or contralateral limb mean that for many patients, once limb-threatening ischemia occurs, the need for treatment is lifelong.
Recognizing this problem, recent efforts to evaluate the results of lower extremity bypass surgery have included assessment of functional outcomes after vascular surgery. Questionnaires such as those described by the Medical Outcomes Study Approach have been developed to assess patient global health status and functioning. 28 One questionnaire, the Peripheral Arterial Disease-Walking Impairment Questionnaire (PAD-WIQ) developed by Regensteiner and colleagues, has been validated for assessment of functional status in patients with claudication. 4 No questionnaire has similarly been validated for assessment of patients who have severe limbthreatening ischemia. The RAND 36-Item Health Survey 1.0, which is identical to the Medical Outcomes Study Short Form, was applied to a group of 38 patients who underwent bypass grafting for limb salvage by Duggan and colleagues. 29 These authors found no difference in health perceptions between patients who had successful limb salvage and patients who had failed bypass grafts that required amputation. It is tempting to conclude that the RAND 36-Item Health Survey that was used simply did not assess appropriate criteria to detect a difference. The results of the present study, which document frequent and prolonged wound complications, frequent need for repeat surgery on both the ipsilateral and contralateral legs, an appreciable incidence of late limb loss, and progressive decline in functional status strongly suggest that the results of Duggan and colleagues' study may be disturbingly accurate.
Global health questionnaires may not adequately assess parameters directly related to limb salvage surgery. Previous studies from our own institution as well as from others have suggested that patient ambulatory status and living status (parameters most directly related to limb salvage) are maintained shortly after bypass surgery. 5, 30 That this is not the case in the long-term is clearly documented in the present study, in which only 68% of patients who were ambulatory and living independently before surgery maintained this status at the time of last follow-up or death. This marked change from early to late postoperative status means that studies of functional status of patients who undergo lower extremity bypass operations must include a majority with at least 3 years of follow-up.
It is unlikely that the present study consists of a patient group with uniquely poor results. The patient demographics, indication for surgery, opera-tions performed, conduits used (Table I) , and the life table calculation of assisted primary patency rate, limb salvage rate, and patient survival rate are well within the range previously reported for IB for limb salvage by many groups, including our own. 7, [14] [15] [16] [17] [18] [19] [20] [21] Recently reported results from Great Britain also document an appreciable requirement for use of health care resources because of wound complications and the need for repeat surgery in the limb salvage patient group. 31, 32 As assessed by the parameters of this study, ideal results of IB are distinctly infrequent. Only 14% of patients had an uncomplicated operation, relief of symptoms, uncomplicated wound healing, no need for repeat surgery, and maintenance of functional status. For the 86% of patients who did not have ideal results, wound care, repeat hospitalizations, and repeat surgery, frequent clinic visits and declining functional status meant that a large portion of the final months of life was occupied with treatment of limb ischemia.
These mostly negative results must be viewed with some caution. The retrospective nature of the study meant that only the most broad parameters regarding functional status could be determined. Because 86% of patients were living independently and were ambulatory before operation, none of these patients could improve after operation, a situation that may have introduced negative bias into the study. It is possible that a detailed prospective study of functional status in patients who undergo IB for limb salvage would have a different outcome.
CONCLUSION
Although clinically important palliation is frequently achieved by IB for limb salvage, ideal results are distinctly infrequent. Most patients who undergo IB for limb salvage require ongoing treatment for significant portions of the remainder of their lives. In view of these results, continued evaluation of alternate approaches to therapy, including nonoperative treatment and primary amputation, appears warranted. It is interesting to speculate that whereas we have spent the past several decades defining the technical limits of what can be done surgically to treat limbthreatening ischemia, we may spend the next period defining when such surgery should be performed. February 1998 Dr. James O. Menzoian (Boston, Mass.). In assessing the outcomes of lower extremity revascularization, it is important to define certain ground rules by which the results of the clinical intervention can be assessed. In reviewing reported results, it is often difficult to decide whether these reports are measuring and defining the outcomes of an operation or defining the outcome from the point of view of the patient. For example, a bypass grafting procedure that was performed for a nonhealing ulcer may in fact continue to function, but in a small percentage of patients the ulcer may persist. In this circumstance the bypass graft is functioning well; however, the patient is not doing well.
Dr. Nicoloff and his colleagues have reported to us today on the results of infrainguinal bypass surgery for limb salvage in 112 patients. In addition to the conventional analysis of results with limb salvage and graft patency rates, they report on the functional outcome of their patients who underwent the surgery. They define an ideal result for infrainguinal bypass grafting for limb salvage to include elimination of ischemia, prompt wound healing, and a rapid return to their premorbid functional status without recurrence. Their assisted primary graft patency and limb salvage rates at 5 years are respectable, as one would expect from this group. Some of their findings, however, are quite sobering.
For the period of follow-up, which was a mean of 42 months, the patient survival rate was 49%. At last followup or death, 73% of the patients who were living independently before operation were still living independently, and 70% of those who were ambulatory before operation remained ambulatory. The operative wound and the ischemic wound for which the bypass procedure was performed required an average of 4.2 months to heal, and 22% of the patients had not achieved complete wound healing at the time of last follow-up. Fifty-four percent of the patients had to undergo another operation during the period of follow-up. Twenty-three percent of the patients ultimately required a major amputation. Only 16 of 112 patients achieved the ideal surgical result. I must reiterate that these sobering results occurred in spite of what we would consider to be an excellent assisted primary graft patency rate of 77% and a limb salvage rate of 87% at 5 years. I would like to ask the authors a few questions.
You have used a kind of functional outcome assessment of your patients but have not done so using any of the traditional quality-of-life assessment tools such as the Rand 36 Item Health Survey or the Medical Outcome Short Form Survey. Had you done so, you may have reported your results in a slightly different manner. These tools have questions regarding how the patient felt about their care and how their general health was after the surgery compared with what it was before the surgery. It is conceivable that the patients might still have opted for the infrainguinal bypass procedure in spite of some of the sobering data you have presented. Do you believe that any of the quality of life assessment tools that are available today are appropriate to be used in our patients who have critical limb ischemia? If a vascular surgeon wanted to incorporate this kind of assessment in his practice, which tool do you think would be most helpful? There has been some criticism that the traditional outcome assessment tools are inappropriate for our patients because our patients are older, have many medical problems, and by the time they reach the point of critical limb ischemia they may be on a downward curve as far as their functional outcome and longevity.
You have listed in your paper many of the demographic descriptions of your patients. I think that these may explain some of your results. For example, 66% of the patients had ulcer gangrene, 53% had diabetes mellitus, 20% had had a previous ipsilateral bypass, and 60% of your bypass grafts were to the tibial or pedal level. Based on your experience with these patients, are you starting to form a profile of patients in whom you anticipate the results might be particularly bad?
I believe your assessment of these patients represents a very comprehensive and honest assessment of the results of infrainguinal bypass surgery for critical limb ischemia. Of course, a comparative treatment such as nonoperation or primary amputation is an option, but do you have any data that either of these two options will result in a better quality-of-life assessment in these critically ill patients?
There is no question that bypass surgery for limbthreatening ischemia is an effective way of rehabilitating some patients and improving their functional status. There are some patients, however, in whom serious consideration needs to be given before recommending vascular reconstruction. Outcome studies such as that reported today will serve to help the clinician gather valuable information that may be helpful in establishing guidelines that will result in improving the quality of life of patients who have peripheral arterial occlusive disease.
Dr. Alexander D. Nicoloff. Thank you, Dr. Menzoian. With regard to your first question, there have been many studies that use questionnaires to analyze outcome after leg bypass surgery for both claudication and limb salvage. The results have been mixed. Although I think that this is an appropriate way to measure the outcomes, we tried to measure it from the point of view of the patient and in an objective manner, particularly by looking at the need for repeat operations and wound healing. The questionnaires, including the Short Form 36 and the Rand questionnaire are subjective and could be biased in some instances.
In response to your question about patient profiles and whether we identified one that would suggest proceeding with alternate therapy, we did not address that specifically in this study. Certainly there were some groups that stood out, for instance, patients with diabetes and renal failure, which may not be a surprise to most of us. Further study is needed to define these subgroups individually.
And with regard to your last question, no, we don't have any data in our study on alternate therapies. That will doubtless be the focus of a future study.
Dr. Keith D. Calligaro (Philadelphia, Pa.). I just have a comment to make. The data you have presented have several significant and, I might say, potentially dangerous implications. In this era of increasing impact of third-party payers and subsequent decreasing reimbursements, those same third-party payers may use these data to suggest what seems to be your ultimate conclusion: that patients with severely ischemic limbs not be subjected to revascularization but simply undergo a primary amputation, which would obviously have profound implications on everyone in this room.
My comment is only that I would request that in your manuscript you carefully mention that the outcome of primary amputations in this same patient group is not really well known. And I might dare to say that almost all of those patients might suggest to you that not having their limb is significantly worse than what they have gone through to achieve limb salvage.
Dr. Nicoloff. Thank you. It is true that we did not look at what patients think of bypass surgery compared with primary amputation. And most assuredly, we are not making any recommendations to change practice policies. The purpose of the study was simply to determine how these patients fared over the long term after limb salvage surgery. We conclude that they fared poorly. We most assuredly are not concluding that any alternative therapy is better.
Dr. George Andros (Encino, Calif.). I would like to congratulate the authors on addressing important outcomes apart from the ones we traditionally use. When we looked at our plantar bypass procedures several years ago in patients with diabetes, we found that a full 30% of those people returned to work. I am wondering whether you investigated another useful outcome: how many people actually return to work in this group, even though the mean age was over 65 years.
I am also a little troubled by any suggestion that we approach these patients with the recommendation for primary amputation on other than a very selective basis. Your data seemed to support being very cautious about the use of primary amputation because you did point out that the most common repeat operation was an operation on the other leg, so you've already got two limbs in play. I'd like you to comment on that.
Dr. Nicoloff. Thank you. In our cohort all but a tiny percentage of patients had retired, so return to work was not a valid endpoint. We did not include this parameter in our study.
With regard to your second question, we do not suggest approaching these patients with the recommendation of primary amputation. Further subgroup analysis, beyond the scope of this study, will be required to even address this issue.
Dr. Frank W. LoGerfo (Boston, Mass.). I want to compliment you on your very nice presentation and for revisiting the palliative nature of what we do in lower extremity arterial reconstruction and, hence, our conservative attitude towards operating on these patients.
I have just one concern about your data. This is a very small number of patients out of the large denominator, of course, that are done at OHSU. The single criterion, as I understand it, was that they underwent their initial bypass procedure at OHSU. One of the things that aroused my concern about this is the mortality rate, 6%, which is higher, I believe, than has been reported in previous publications. I also noticed in the abstract that there were 77 patients at the time it was written, with two deaths. Presented here are 112 patients with seven deaths. So that, by my calculations, of those 35 patients who were added five died, or a 14% operative mortality rate. So I just wondered about that. Is there something about this cohort that is extremely high-risk as compared with the broader number of patients who undergo this operation?
Finally, I do think that it is important to say that this is something that may be true but only somewhat related to whether we should operate on these patients. We can still perform arterial reconstruction with a low mortality rate, a high patency rate, and we can save their legs.
Dr. Nicoloff. Yes, the operative mortality rate of the patients, at 6%, is higher than in previous studies that we have presented. I have no way to really explain this other than that this study looks at a 3-year interval of consecutive operations performed about 5 years ago, whereas the other previously reported data are over a longer period-10 years or so. So I have no explanation of why the mortality rate is higher in these consecutive patients over the relatively short 3-year study interval. But with regard to other demographics, risk factors, and morbidity, this study group is substantially the same as the previous populations that we have studied.
The lower operative mortality rate in the preliminary abstract to which you refer was calculated before obtaining complete follow-up on many patients, three or four of whom were found to have died after hospital discharge but within the 30-day operative period, which accounts for the difference in the mortality figure.
Dr. James M. Malone (Phoenix, Ariz.). Once again, Dr. Porter's group has given us a very provocative paper, and it would indeed be interesting to see randomization between amputation and limb bypass surgery. Of all the people in the audience who can speak to lower limb amputation, I should probably be the one to rise to say that limb amputation also has measurable standards much like distal bypass grafting does, as presented in this paper. As amputation surgeons, we don't think in terms of patency, but we do think in terms of continued successful ambulation, avoidance of pain, and avoidance of reoperation. Long-term results from our immediate postoperative prosthesis fit group demonstrate remarkably similar data. About half of the patients are dead at 5 years. Approximately 98% of the surviving patients still continue to ambulate, an observation that would at first glance perhaps suggest that amputation would be the treatment of choice. However, the whole issue really revolves around February 1998 the ideal of what is trying to be accomplished. If you would ask the individual with an amputation whether walking is satisfactory, I would think that the mass of our patients would answer yes. The complexing issue, obviously, is whether it is ideal to be able to ambulate or to keep your leg? I don't think any of us are going to be able to solve that dilemma today.
In addition, as one other discussant mentioned, it is very depressing when every time you perform a distal bypass procedure you are cautioned by your hospital CEO that the hospital has lost money, and yet every time you perform a primary amputation and get the patient out the door walking you are congratulated for saving the hospital money. The paper was very provocative and very well presented.
Dr. Nicoloff. Thank you. A considerable amount of literature indicates that primary amputation has an outcome equal to or slightly worse than that of limb salvage attempts. One reason for this is that patients who undergo primary amputation tend to have more comorbidities and are sicker. It is difficult to compare these patient groups because a prospective, randomized study of revascularization compared with primary amputation cannot be performed.
There is one study by Hoghton and his associates that showed that patients who underwent amputation after failed revascularization maintained their mobility better in comparison with patients who underwent revascularization. This might be a closer match than comparing patients who undergo revascularization with patients selected for primary amputation.
It is important to keep in mind that we are in no way recommending primary amputation. Our only objective was to attempt to accurately describe what happened to this cohort after limb salvage surgery.
Dr. Gary R. Seabrook (Milwaukee, Wis.). A study of functional outcomes in our patients would agree with the findings of your report. In data presented at the Midwestern Vascular Society meeting 2 years ago, we sought to measure function and health-related quality of life using a modification of the SF-36. In fact, that instrument can be difficult to administer to an elderly population because of the complexity of the rating scales, and some questions simply don't pertain to the activities of these older adults.
We have found that patients who have undergone successful arterial revascularization for limb salvage are as functional as age-matched controls only in tasks of dressing themselves and using the toilet when assessed for a wide variety of physical activities. Patients who have undergone infrainguinal bypass grafting perform very similarly to amputees with functional prostheses.
These data should not discourage us from performing operations for limb salvage or investigating their outcomes. We need to document that our patients are, in fact, very disabled even when their limbs have been preserved. This information identifies the vast amount of care that these patients will require for their lifetime.
Dr. Nicoloff. Thank you, Dr. Seabrook, for your comments. I agree with them completely, as they basically describe the bottom line of our paper. Not only does this information support the vast amount of care that these patients will need, but hopefully will also help in further advising patients and referring physicians of what is involved over the long term when infrainguinal bypass grafting for limb salvage is undertaken.
